Skip to main content
Top
Published in: Journal of Gastroenterology 12/2011

01-12-2011 | Original Article—Liver, Pancreas, and Biliary Tract

Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage

Authors: Hirofumi Kogure, Takeshi Tsujino, Keisuke Yamamoto, Suguru Mizuno, Yoko Yashima, Hiroshi Yagioka, Kazumichi Kawakubo, Takashi Sasaki, Yousuke Nakai, Kenji Hirano, Naoki Sasahira, Hiroyuki Isayama, Minoru Tada, Takao Kawabe, Masao Omata, Sohei Harada, Yasuo Ota, Kazuhiko Koike

Published in: Journal of Gastroenterology | Issue 12/2011

Login to get access

Abstract

Background

The current management of acute cholangitis consists of antibiotic therapy in combination with biliary drainage. However, the optimal duration of antibiotic therapy after the resolution of clinical symptoms by biliary drainage is unclear. We aimed to evaluate whether discontinuing antibiotic therapy for acute cholangitis immediately after the resolution of clinical symptoms, achieved by endoscopic biliary drainage, was safe and effective.

Methods

This prospective study included patients with moderate and severe acute cholangitis. Cefmetazole sodium and meropenem hydrate were used as initial antibiotic therapy for patients with moderate and severe acute cholangitis, respectively. All patients underwent endoscopic biliary drainage within 24 h of diagnosis. When the body temperature of <37°C was maintained for 24 h, administration of antibiotics was stopped. The primary endpoint was the recurrence of acute cholangitis within 3 days after the withdrawal of antibiotic therapy.

Results

Eighteen patients were subjected to the final analysis. The causes of cholangitis were bile duct stone (n = 17) and bile duct cancer (n = 1). The severity of acute cholangitis was moderate in 14 patients and severe in 4. Body temperature of <37°C was achieved in all patients after a median of 2 days (range 1–6) following endoscopic biliary drainage. Antibiotic therapy was administered for a median duration of 3 days (range 2–7). None of the patients developed recurrent cholangitis within 3 days after the withdrawal of antibiotics.

Conclusions

Fever-based antibiotic therapy for acute cholangitis is safe and effective when resolution of fever is achieved following endoscopic biliary drainage.
Literature
1.
go back to reference Tokyo Guidelines for the management of acute cholangitis and cholecystitis. Proceedings of a consensus meeting, April 2006, Tokyo, Japan. J Hepatobiliary Pancreat Surg. 2007;14:1–121. Tokyo Guidelines for the management of acute cholangitis and cholecystitis. Proceedings of a consensus meeting, April 2006, Tokyo, Japan. J Hepatobiliary Pancreat Surg. 2007;14:1–121.
2.
go back to reference Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin N Am. 1990;70:1297–312.PubMed Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin N Am. 1990;70:1297–312.PubMed
3.
go back to reference Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg. 1989;209:435–8.PubMedCrossRef Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg. 1989;209:435–8.PubMedCrossRef
4.
go back to reference Cohen SA, Siegel JH. Biliary tract emergencies. Endoscopic and medical management. Crit Care Clin. 1995;11:273–94.PubMed Cohen SA, Siegel JH. Biliary tract emergencies. Endoscopic and medical management. Crit Care Clin. 1995;11:273–94.PubMed
5.
go back to reference Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin N Am. 2000;14:521–46.CrossRef Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin N Am. 2000;14:521–46.CrossRef
6.
go back to reference Kadakia SC. Biliary tract emergencies. Acute cholecystitis, acute cholangitis, and acute pancreatitis. Med Clin North Am. 1993;77:1015–36.PubMed Kadakia SC. Biliary tract emergencies. Acute cholecystitis, acute cholangitis, and acute pancreatitis. Med Clin North Am. 1993;77:1015–36.PubMed
7.
go back to reference Sievert W, Vakil NB. Emergencies of the biliary tract. Gastroenterol Clin North Am. 1988;17:245–64. Sievert W, Vakil NB. Emergencies of the biliary tract. Gastroenterol Clin North Am. 1988;17:245–64.
8.
go back to reference Lillemoe KD. Surgical treatment of biliary tract infections. Am Surg. 2000;66:138–44.PubMed Lillemoe KD. Surgical treatment of biliary tract infections. Am Surg. 2000;66:138–44.PubMed
9.
go back to reference Andrew DJ, Johnson SE. Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition. Am J Gastroenterol. 1970;54:141–54.PubMed Andrew DJ, Johnson SE. Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition. Am J Gastroenterol. 1970;54:141–54.PubMed
10.
go back to reference Shimada H, Nakagawara G, Kobayashi M, Tsuchiya S, Kudo T, Morita S. Pathogenesis and clinical features of acute cholangitis accompanied by shock. Jpn J Surg. 1984;14:269–77.PubMedCrossRef Shimada H, Nakagawara G, Kobayashi M, Tsuchiya S, Kudo T, Morita S. Pathogenesis and clinical features of acute cholangitis accompanied by shock. Jpn J Surg. 1984;14:269–77.PubMedCrossRef
11.
go back to reference Thompson JE Jr, Pitt HA, Doty JE, Coleman J, Irving C. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet. 1990;171:275–82.PubMed Thompson JE Jr, Pitt HA, Doty JE, Coleman J, Irving C. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet. 1990;171:275–82.PubMed
12.
go back to reference Tai DI, Shen FH, Liaw YF. Abnormal pre-drainage serum creatinine as a prognostic indicator in acute cholangitis. Hepatogastroenterology. 1992;39:47–50.PubMed Tai DI, Shen FH, Liaw YF. Abnormal pre-drainage serum creatinine as a prognostic indicator in acute cholangitis. Hepatogastroenterology. 1992;39:47–50.PubMed
13.
go back to reference Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, et al. Emergency surgery for severe acute cholangitis. The high-risk patients. Ann Surg. 1990;211:55–9.PubMedCrossRef Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, et al. Emergency surgery for severe acute cholangitis. The high-risk patients. Ann Surg. 1990;211:55–9.PubMedCrossRef
15.
go back to reference Chijiiwa K, Kozaki N, Naito T, Kameoka N, Tanaka M. Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis. Am J Surg. 1995;170:356–60.PubMedCrossRef Chijiiwa K, Kozaki N, Naito T, Kameoka N, Tanaka M. Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis. Am J Surg. 1995;170:356–60.PubMedCrossRef
16.
go back to reference Tsujino T, Sugita R, Yoshida H, Yagioka H, Kogure H, Sasaki T, et al. Risk factors for acute suppurative cholangitis caused by bile duct stones. Eur J Gastroenterol Hepatol. 2007;19:585–8.PubMedCrossRef Tsujino T, Sugita R, Yoshida H, Yagioka H, Kogure H, Sasaki T, et al. Risk factors for acute suppurative cholangitis caused by bile duct stones. Eur J Gastroenterol Hepatol. 2007;19:585–8.PubMedCrossRef
17.
go back to reference Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326:1582–6.PubMedCrossRef Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326:1582–6.PubMedCrossRef
18.
go back to reference van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.PubMedCrossRef van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.PubMedCrossRef
19.
go back to reference Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs. 1999;57:81–91.PubMedCrossRef Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs. 1999;57:81–91.PubMedCrossRef
20.
go back to reference Dooley JS, Hamilton-Miller JM, Brumfitt W, Sherlock S. Antibiotics in the treatment of biliary infection. Gut. 1984;25:988–98.PubMedCrossRef Dooley JS, Hamilton-Miller JM, Brumfitt W, Sherlock S. Antibiotics in the treatment of biliary infection. Gut. 1984;25:988–98.PubMedCrossRef
21.
go back to reference van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM. Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc. 2002;55:518–22.PubMedCrossRef van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM. Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc. 2002;55:518–22.PubMedCrossRef
22.
go back to reference Tsujino T, Kawabe T, Komatsu Y, Yoshida H, Isayama H, Sasaki T, et al. Endoscopic papillary balloon dilation for bile duct stone: immediate and long-term outcomes in 1000 patients. Clin Gastroenterol Hepatol. 2007;5:130–7.PubMedCrossRef Tsujino T, Kawabe T, Komatsu Y, Yoshida H, Isayama H, Sasaki T, et al. Endoscopic papillary balloon dilation for bile duct stone: immediate and long-term outcomes in 1000 patients. Clin Gastroenterol Hepatol. 2007;5:130–7.PubMedCrossRef
23.
go back to reference Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–34.PubMedCrossRef Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–34.PubMedCrossRef
24.
go back to reference Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.PubMedCrossRef Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.PubMedCrossRef
25.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.PubMedCrossRef Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.PubMedCrossRef
26.
go back to reference Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS. The Sanford guide to antimicrobial therapy. 39th ed. Antimicrobial Therapy, Inc., Sperryville, VA, 2009. Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS. The Sanford guide to antimicrobial therapy. 39th ed. Antimicrobial Therapy, Inc., Sperryville, VA, 2009.
27.
go back to reference Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716–21.PubMed Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716–21.PubMed
28.
go back to reference Sung JJ, Lyon DJ, Suen R, Chung SC, Co AL, Cheng AF, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. J Antimicrob Chemother. 1995;35:855–64.PubMedCrossRef Sung JJ, Lyon DJ, Suen R, Chung SC, Co AL, Cheng AF, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. J Antimicrob Chemother. 1995;35:855–64.PubMedCrossRef
Metadata
Title
Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage
Authors
Hirofumi Kogure
Takeshi Tsujino
Keisuke Yamamoto
Suguru Mizuno
Yoko Yashima
Hiroshi Yagioka
Kazumichi Kawakubo
Takashi Sasaki
Yousuke Nakai
Kenji Hirano
Naoki Sasahira
Hiroyuki Isayama
Minoru Tada
Takao Kawabe
Masao Omata
Sohei Harada
Yasuo Ota
Kazuhiko Koike
Publication date
01-12-2011
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 12/2011
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-011-0451-5

Other articles of this Issue 12/2011

Journal of Gastroenterology 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine